Stock Research for AGN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AGN Stock Chart & Research Data

The AGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AGN Due diligence Resources & Stock Charts

The AGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AGN Detailed Price Forecast - CNN Money CNN View AGN Detailed Summary - Google Finance
Yahoo View AGN Detailed Summary - Yahoo! Finance Zacks View AGN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AGN Trends & Analysis - Trade-Ideas Barrons View AGN Major Holders - Barrons
NASDAQ View AGN Call Transcripts - NASDAQ Seeking View AGN Breaking News & Analysis - Seeking Alpha
Spotlight View AGN Annual Report - CompanySpotlight.com OTC Report View AGN OTC Short Report - OTCShortReport.com
TradeKing View AGN Fundamentals - TradeKing Charts View AGN SEC Filings - Bar Chart
WSJ View Historical Prices for AGN - The WSJ Morningstar View Performance/Total Return for AGN - Morningstar
MarketWatch View the Analyst Estimates for AGN - MarketWatch CNBC View the Earnings History for AGN - CNBC
StockMarketWatch View the AGN Earnings - StockMarketWatch MacroAxis View AGN Buy or Sell Recommendations - MacroAxis
Bullish View the AGN Bullish Patterns - American Bulls Short Pains View AGN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AGN Stock Mentions - StockTwits PennyStocks View AGN Stock Mentions - PennyStockTweets
Twitter View AGN Stock Mentions - Twitter Invest Hub View AGN Investment Forum News - Investor Hub
Yahoo View AGN Stock Mentions - Yahoo! Message Board Seeking Alpha View AGN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AGN - SECform4.com Insider Cow View Insider Transactions for AGN - Insider Cow
CNBC View AGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AGN - OTC Markets
Yahoo View Insider Transactions for AGN - Yahoo! Finance NASDAQ View Institutional Holdings for AGN - NASDAQ


Stock Charts

FinViz View AGN Stock Insight & Charts - FinViz.com StockCharts View AGN Investment Charts - StockCharts.com
BarChart View AGN Stock Overview & Charts - BarChart Trading View View AGN User Generated Charts - Trading View




Latest Financial News for AGN


Aurinia Pharmaceuticals Has Lots of Upside Potential
Posted on Friday July 13, 2018

Since last year, Aurinia Pharmaceuticals (NASDAQ:AUPH) has moved very little on the stock market. News of the launch of a mid-stage study, along with a quarterly earnings report before that, failed to ignite or hurt AUPH stock by much. On July 11, Aurinia launched a mid-stage Phase 2 clinical study that evaluates its drug, Voclosporin, for treating dry eye syndrome (or DES).


See what the IHS Markit Score report has to say about Allergan plc.
Posted on Thursday July 12, 2018

Allergan plc NYSE:AGN


Examining Allergan: Cramer Goes 'Off the Charts'
Posted on Wednesday July 11, 2018

shares have been on a three-year jag, prompting many investors, including Jim Cramer and the team at his Action Alerts Plus investment club, to throw in the towel on the botox maker. During the shows "Off the Charts" segment, Cramer and Collins started with a weekly chart of Allergan showing part of the brutal decline the stock has suffered from the $250s last summer down to $142 earlier this spring. While Allergan has had a consistent floor of support in the $140s to $150s, its ceiling of resistance has changed.


Don't get too excited about Botox maker Allergan
Posted on Tuesday July 10, 2018

Jim Cramer and technician Tim Collins review Allergan's stock charts to figure out what might be next for the Botox maker.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.